Associations between muscle measures, survival, and toxicity in patients with limited stage small cell lung cancer

BACKGROUND: Standard treatment for patients with limited stage small cell lung cancer (LS SCLC) is concurrent platinum–etoposide chemotherapy and thoracic radiotherapy (TRT). Up to 30% of patients are cured, but severe toxicity is common, and we are not able to identify those who are cured or those...

Descripción completa

Detalles Bibliográficos
Autores principales: Halvorsen, Tarje Onsøien, Valan, Christine Damgaard, Slaaen, Marit, Grønberg, Bjørn Henning
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7567150/
https://www.ncbi.nlm.nih.gov/pubmed/32725772
http://dx.doi.org/10.1002/jcsm.12583

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7567150/
https://www.ncbi.nlm.nih.gov/pubmed/32725772
http://dx.doi.org/10.1002/jcsm.12583

Ejemplares similares